00:00 Mr Speaker a
According to the latest report from Harvard Belfer Center for Science and International Affairs, China has a speedy opportunity to get the United States with biotechnology. For more, let us receive in ARTA Rawi American market and military market and the health of Health, and Anjali Circle of Anjali. Welcome to both. Okay, I will start with you. Uh, maybe it’s a great question, a big question of image. Does the US have the ability to invest, in your opinion, to find China in a biotech?
01:05 Arta Rawi
Yes, thank you for being with me. UH, biotech is a thing of feres in new new medicines and only uh trembles well in ecosystem. So to answer your question, what do you need in that raising sense? Uh, the investment capacity, which we had the last, knows, decades, if you would continue to invest in that doctor to continue. It is probably the largest VC of VC in 40 billion 3 billion in the non-defeat cash in business entities. Then talent has always been, you know, coming all these upper universities and MDS and PHDs dedicated to trembling. And then you need this technology transfer system for those logs at first. And then the investment in the investment, it goes on growing and trying to go to people and finally developed for everyone’s use. Thus, Uh, yes, the US is still able to invest, but is not the only game in the city given development from China.
03:01 Anjali Carlani
I’m curious, Arra, because we know, I know you have tracked deals with UH, we’ve seen the number of strong antils over the years. I saw, Uh, one of those who sent it, who looked at the number of deals so far that 2025 was more than half of what we saw in 2024. What does that mean? Because I know that some deals happening is more, Om, what can you pronounce payment licenses, isn’t it? It is not necessarily that this money will move from the investment at the beginning and from the sequence, but many things already happened and are built. Talk to me about that and why that is important.
04:07 Arta Rawi
I mean, first, numbers are compulsory. A few years ago, we had a great deal of less than a billion dollars in 2016. And since last year, there was a $ 30 license is a very strong start, so we will hit that number. So why this happened in 2015, a group of Chinese Communists put the most important investment in biotech investment and that was the most important areas. And it was 10 years ago, and the 10 years of the journey began playing their profits because China historically became known for these practical product appos and Excipients, such as chemicals used by molecules. And that moves now takes them to go up to further new foundation. We probably did not first see the classroom, but it is clearly that they will know good in the class, like those.
05:44 Anjali Carlani
Yes, that’s why I can be my question because I know we have seen how they can make Copycats or metoos in Innovation out of China. Me, we expect that they have an ITfy outside the US at that time, according to the next international Blockbuster?
06:12 Arta Rawi
I mean there are few examples, examples of the Chinese goods are actually compared to heads, you know, hit, to match the successful and security profile of some Western composition. But this is also a journey as an audio question. So, what do they need to get there? So they have talent. I mean that many educated MDS has learned West and PhDs returned to China working on that. Government person as part of the program to build investment. The question is therefore, having a plan for exits from those businessmen? And that I think they are scarce because there is nothing like the IPO market compared to Western levels. There is no as m & a punt out until recently. I think that’s the weakness of the kind to be the opportunity to climb. But the deals we were talking about, because of the problems of the intelligent property, because of the concerns of trust and trust in the details because, you know, no current institution worldwide and hopefully we continue relying. And because of this reason, deals that seem to be purchased. So I do not risk working in China, but I am in a license, and I will continue to do so early and can be done, human assurance can be done, human assurance can be done, human assurance can be made, human assurance can be made, human assurance can be made, human assurance can be made, man’s assurance can be made, human assurance may be made, man’s assurance may be made, man’s assurance can be made, man’s assurance can be made, man’s assurance can be made, man confirmation. It can be done, human assurance can be made, human assurance can be made, human assurance can be made, human assurance can be made, personal assurance can be made, personal assurance can be done, verification may be made, verification may be made, confirmation Personal can be made, personal assurance can be made, personal assurance can be made, personal assurance can be made in the western system. I think that can be a winning formula in the industry.
